8
Views
5
CrossRef citations to date
0
Altmetric
Original

Effects of Naloxone and Verapamil in Experimental Amitriptyline Poisoning in Rats

, , M.D., Ph.D. &
Pages 313-324 | Published online: 31 Jan 2011

References

  • Faden A. I., Holaday J. W. Opiate antagonists: a role in the treatment of hypovolemic shock. Science 1979; 205: 317–318
  • Reynolds D. G., Gurll N. J., Varglsh T., Lechner R. B., Faden A. I., Holaday J. W. Blockade of opiate receptors with naloxone Improves survival and cardiac performance in canine endotoxic shock. Circ. Shock 1980; 7: 39–48
  • Schadt J. C., York D. H. Involvement of both adrenergic and cholinergic receptors in the cardiovascular effects of naloxone during hemorrhagic hypotension in the conscious rabbit. J. Autonom. Nerv. Syst. 1982; 6: 237–251
  • Holaday J. W., Faden A. I. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation 1n spinal shock. Brain Research 1980; 189: 295–299
  • Ferlinz J., Easthope J. L., Aronow W. S. Effects of verapamil on myocardial performance in coronary disease. Circulation 1979; 59(2)313–319
  • Heikkila J., Nieminen M. Effects of verapamil in patients with acute myocardial Infarction; hemodynamlcs and function of normal and Ischémie left ventricular function. Am. Heart J. 1984; 107(2)241–247
  • El-Hage A., Balazs T., West W. L. Protective effects of clonidine and verapamil in experimental amitriptyllne poisoning in rabbits. J. Toxicol. CUn. Toxicol. 1982; 19(3)321–335
  • Fllias N., Jornad J. Les complications cardiovasculalres des antidépresseurs trlcycUques. Revue Médicale de la Suisse Romanade 1973; 93: 1005–1012
  • Frommer D., Kullg K., Marx J., Rumack B. Tricycllc antldepressant poisoning. JAMA 1987; 257: 4
  • Dirksen R., Otten M. H., Wood G. J., Verbaan C. J., Haalebos M. M. P., Verdouw P. V., Nijhuis G. M. M. Naloxone 1n shock. Lancet 1980; 27(2)1360–1361
  • Vestl Nielsen J., Lundgren L.-G. Naloxone och endogena opiater v1d chock. Lakart1dn1ngen 1984; 81(41)3717
  • Andersson K.-E., Hogestatt E. D. On the mechanism of action of calcium antagonists. Acta Medlca Scand. 1982; 681: 11–24, (Suppl)
  • Rosen M., Ilvento J. P., Gelband H., Merker C. Effects of verapamll on electrophyslologlcal properties of canine cardiac Purklnje fibers. J. Pharmacol. Exp. Ther. 1974; 189: 414
  • Schamroth L. Verapamll: recommendations and caveats. J. Cardlovasc. Med. 1984; 9(3)206–214
  • Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Ann. Rev. Pharmacol. Toxlcol. 1977; 17: 149–166

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.